Immune System Modulation by the Adjuvants Poly (I:C) and Montanide ISA 720
- PMID: 35844531
- PMCID: PMC9278660
- DOI: 10.3389/fimmu.2022.910022
Immune System Modulation by the Adjuvants Poly (I:C) and Montanide ISA 720
Abstract
Adjuvants are essential for vaccine development, especially subunit-based vaccines such as those containing recombinant proteins. Increasing the knowledge of the immune response mechanisms generated by adjuvants should facilitate the formulation of vaccines in the future. The present work describes the immune phenotypes induced by Poly (I:C) and Montanide ISA 720 in the context of mice immunization with a recombinant protein based on the Plasmodium vivax circumsporozoite protein (PvCSP) sequence. Mice immunized with the recombinant protein plus Montanide ISA 720 showed an overall more robust humoral response, inducing antibodies with greater avidity to the antigen. A general trend for mixed Th1/Th2 inflammatory cytokine profile was increased in Montanide-adjuvanted mice, while a balanced profile was observed in Poly (I:C)-adjuvanted mice. Montanide ISA 720 induced a gene signature in B lymphocytes characteristic of heme biosynthesis, suggesting increased differentiation to Plasma Cells. On the other hand, Poly (I:C) provoked more perturbations in T cell transcriptome. These results extend the understanding of the modulation of specific immune responses induced by different classes of adjuvants, and could support the optimization of subunit-based vaccines.
Keywords: Plasmodium vivax; immune response; montanide; poly (I:C); vaccine.
Copyright © 2022 Marques, de Melo, Novais, Soares, Bargieri and Gimenez.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle.Vaccine. 2013 Jul 18;31(33):3327-32. doi: 10.1016/j.vaccine.2013.05.078. Epub 2013 Jun 2. Vaccine. 2013. PMID: 23735678
-
Immunoenhancing effects of Montanide ISA oil-based adjuvants on recombinant coccidia antigen vaccination against Eimeria acervulina infection.Vet Parasitol. 2010 Sep 20;172(3-4):221-8. doi: 10.1016/j.vetpar.2010.04.042. Epub 2010 May 12. Vet Parasitol. 2010. PMID: 20541870
-
Long-lasting humoral and cellular immune responses elicited by immunization with recombinant chimeras of the Plasmodium vivax circumsporozoite protein.Vaccine. 2014 Apr 17;32(19):2181-7. doi: 10.1016/j.vaccine.2014.02.053. Epub 2014 Feb 28. Vaccine. 2014. PMID: 24582631
-
Preclinical vaccine study of Plasmodium vivax circumsporozoite protein derived-synthetic polypeptides formulated in montanide ISA 720 and montanide ISA 51 adjuvants.Am J Trop Med Hyg. 2011 Feb;84(2 Suppl):21-7. doi: 10.4269/ajtmh.2011.10-0110. Am J Trop Med Hyg. 2011. PMID: 21292874 Free PMC article.
-
Peptide emulsions in incomplete Freund's adjuvant create effective nurseries promoting egress of systemic CD4+ and CD8+ T cells for immunotherapy of cancer.J Immunother Cancer. 2022 Sep;10(9):e004709. doi: 10.1136/jitc-2022-004709. J Immunother Cancer. 2022. PMID: 36939214 Free PMC article. Review.
Cited by
-
Characterisation of the merozoite thrombospondin related anonymous protein (MTRAP) of Plasmodium berghei as a transmission-blocking antigen.Mem Inst Oswaldo Cruz. 2024 Mar 22;119:e230217. doi: 10.1590/0074-02760230217. eCollection 2024. Mem Inst Oswaldo Cruz. 2024. PMID: 38537036 Free PMC article.
-
Recombinant full-length Bacillus Anthracis protective antigen and its 63 kDa form elicits protective response in formulation with addavax.Front Immunol. 2023 Jan 12;13:1075662. doi: 10.3389/fimmu.2022.1075662. eCollection 2022. Front Immunol. 2023. PMID: 36713362 Free PMC article.
-
Transcriptional Systems Vaccinology Approaches for Vaccine Adjuvant Profiling.Vaccines (Basel). 2025 Jan 1;13(1):33. doi: 10.3390/vaccines13010033. Vaccines (Basel). 2025. PMID: 39852812 Free PMC article.
-
Poly I:C elicits broader and stronger humoral and cellular responses to a Plasmodium vivax circumsporozoite protein malaria vaccine than Alhydrogel in mice.Front Immunol. 2024 Apr 8;15:1331474. doi: 10.3389/fimmu.2024.1331474. eCollection 2024. Front Immunol. 2024. PMID: 38650939 Free PMC article.
-
Immunogenicity assessment of Hepatitis A-VP1 and Hepatitis B surface antigen (HBsAg) fusion protein: a novel bivalent vaccine candidate.Iran J Microbiol. 2025 Aug;17(4):636-643. doi: 10.18502/ijm.v17i4.19257. Iran J Microbiol. 2025. PMID: 40785716 Free PMC article.
References
-
- World Health Organization . World Malaria Report 2021. Geneva, Switzerland: WHO; (2021).
-
- Lodaya RN, Gregory S, Amiji MM, O'hagan DT. Practical Aspects of Vaccine Development. Overview of Vaccine Adjuvants. USA: Elsevier, Inc; (2022). doi: 10.1016/C2017-0-01489-1 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases